Produktname:(R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide

IUPAC Name:(4R)-4-methyl-1,3,2λ⁶-dioxathiolane-2,2-dione

CAS:1006381-03-8
Molekulare Formel:C3H6O4S
Reinheit:97%
Katalognummer:CM199586
Molekulargewicht:138.14

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM199586-1g in stock œǠ
CM199586-5g in stock ǺdžƩ
CM199586-25g in stock œƚȤ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1006381-03-8
Molekulare Formel:C3H6O4S
Schmelzpunkt:-
SMILES-Code:C[C@H]1OS(OC1)(=O)=O
Dichte:
Katalognummer:CM199586
Molekulargewicht:138.14
Siedepunkt:
Mdl-Nr.:
Lagerung:

Column Infos

Orforglipron
Obesity is becoming an increasingly serious public health problem globally, plaguing millions of people and significantly increasing their risk of chronic diseases such as diabetes and heart disease. In recent years, with the approval of new weight loss drugs such as Wegovy (Semaglutide) and Mounjaro (Tirzepatide), people's attention to this field has once again heated up, spawning an upsurge in the research and development of new treatments. There are currently nearly 70 obesity treatments in the research and development stage. Eli Lilly's Orforglipron is the world's first oral small molecule GLP-1RA to start Phase III clinical trials.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.